Association of methylenetetrahydrofolate reductase gene polymorphism with carotid arterial wall thickening and myocardial infarction risk in NIDDM

Diabetes

Volumn 46, Issue 12, 1997, Pages 2102-2104

  Aral, Katsumi ^a   Yamasaki, Yoshimitsu ^a   Kajimoto, Yoshitaka ^a   Watada, Hirotaka ^a   Umayahara, Yutaka ^a   Kodama, Mineo ^a   Sakamoto, Ken'ya ^a   Hori, Masatsugu ^a  

^a OSAKA UNIVERSITY MEDICAL SCHOOL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2);

AMINO ACID SUBSTITUTION; ARTERY INTIMA PROLIFERATION; ARTICLE; BLOOD SAMPLING; CAROTID ARTERY; DNA POLYMORPHISM; ENZYME ACTIVITY; GENE MUTATION; HEART INFARCTION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HYPERHOMOCYSTEINEMIA; NON INSULIN DEPENDENT DIABETES MELLITUS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL;

EID: 0030728742     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diab.46.12.2102     Document Type: Article

References (16)

1. Kang SS, Wong PWK, Malinow MR: Hyperhomocyst(e)inemia as a risk factor for occlusive vascular disease. Annu Rev Nutr 12:279-298, 1992
2. Robinson K, Mayer EL, Miller DP, Green R, van Lente F, Gupta A, Kottke-Marchant K, Savon SR, Selhub J, Nissen SE, Kutner M, Topol EJ, Jacobson DW: Hyperhomocysteinemia and low pyridoxal phosphate: common and independent reversible risk factors for coronary artery disease. Circulation 92:2825-2830, 1995
3. Verhoef P, Hennekens CH, Malinow MR, Kok FJ, Willett WC, Stampfer MJ: A prospective study of plasma homocyst(e)ine and risk of ischemic stroke. Stroke 25:1924-1930, 1994
4. Boushey CJ, Beresford SA, Omenn GS, Motulsky AG: A quantitative assessment of plasma homocysteine as a risk factor for vascular disease: probable benefits of increasing folic acid intakes. JAMA 274:1049-1057, 1995
5. Engbersen AMT, Franken DG, Boers GHJ, Stevens EMB, Trijbels FJM, Blom HJ: Thermolabile 5,10-methylenetetrahydrofolate reductase as a cause of mild hyperhomocysteinemia. Am J Hum Genet 56:142-150,1995
6. Kangs SS, Wong PWK, Susmano A, Sora J, Norusis M, Ruggie N: Thermolabile methylenetetrahydrofolate reductase: an inherited risk factor for coronary artery disease. Am J Hum Genet 48:536-545, 1991
7. Frosst P, Blom HJ, Milos R, Goyette P, Sheppard CA, Matthewes RG, Boers GJH, den Heijer M, Kluijtmans LAJ, van den Heuvel LP, Rozan R: A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nature Genetics 10:111-113, 1995
8. Christensen B, Frosst P, Lussier-Cacan S, Selhub J, Goyette P, Rosenblatt DS, Genest J Jr, Rozen R: Correlation of a common mutation in the methylenetetrahydrofolate reductase gene with plasma homocysteine in patients with premature coronary artery disease. Arterioscler Thromb Vase Biol 17:569-573, 1997
9. Araki A, Sako Y: Determination of free and total homocysteine in human plasma by high-performance liquid chromatography with fluorescence detection. J Chromatogr B 422:43-52, 1987
10. Kawamori R, Yamasaki Y, Matsushima H, Nishizawa H, Nao K, Hougaku H, Maeda H, Handa N, Matsumoto M, Kamada T: Prevalence of carotid atherosclerosis in diabetic patients: ultrasound high-resolution B-mode imaging on carotid arteries. Diabetes Care 15:1290-1294, 1992
11. Yamasaki Y, Kawamori R, Matsushima H, Nishizawa H, Kodama M, Kajimoto Y, Morishima T, Kamada T: Atherosclerosis in carotid artery of young IDDM patients monitored by ultrasound high-resolution B-mode imaging. Diabetes 43:634-639, 1994
12. van Bockxmeer FM, Mamotte CDS, Vasikaran SD, Taylor RR: Methylenetetrahydrofolate reductase gene and coronary heart disease. Circulation 95:21-23, 1997
13. Schmitz C, Lindpaintner K, Verhoef P, Gaziano JM, Buring J: Genetic polymorphism of methylenetetrahydrofolate reductase and myocardial infarction: a case control study. Circulation 94:1812-1814, 1996
14. Ma J, Stampfer MJ, Hennekens CH, Frosst P, Selhub J, Horsford J, Malinow MR, Willett WC, Rosen R: Methylenetetrahydrofolate reductase polymorphism, plasma folate, homocysteine, and risk of myocardial infarction in U.S. physicians. Circulation 94:2410-2416, 1996
15. Kluijtmans LAJ, van den Heuvel LPWJ, Boers GHJ, Frosst P, Stevens EMB, van Oost BA, den Heijer M, Trijbels FJM, Rozen R, Blom HJ: Molecular genetic analysis in mild hyperhomocysteinemia: a common mutation in the methylenetetrahydrofolate reductase gene is a genetic risk factor for cardiovascular disease. Am J Hum Genet 58:35-41, 1996
16. Franken DG, Boers GHJ, Blom HJ, Trijbels FJM, Kloppenborg PWC: Treatment of mild hyperhomocysteinemia in vascular disease patients. Atheroscler Thromb 14:465-470, 1994